Manage Johnson & Johnson medical device orders and product-related information all in one location. • Place orders and check order status • Generate price inquiries • View product …

J&J Vision Pro, your go-to resource for eye care professionals. Access cutting-edge products, educational materials, and expert support in one platform.

Major US/EU approvals and submissions and phase 2/3 clinical data presentations being planned or achieved for the year. Information about our Innovative Medicine patent portfolio.

4 days ago · Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial.

SPRING HOUSE, Pa. (November 18, 2024) – Johnson & Johnson (NYSE: JNJ) today announced positive topline results from ICONIC-LEAD a, a pivotal Phase 3 investigational study of …

2 days ago · Patients with plaque psoriasis treated with Johnson & Johnson’s oral IL-23 inhibitor JNJ-2113 have been shown to maintain skin clearance for up to a year, pointing to a durable …

Nov 19, 2024 · Johnson & Johnson’s latest prospective offering to the IL-23 psoriasis space—a Protagonist Therapeutics-partnered once-daily oral peptide—has passed a phase 3 …

WARNING NOTICE: This system is restricted solely to Johnson & Johnson users for legitimate business only. The actual or attempted unauthorized access, use or modification of this …

Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous …

Learn about Johnson & Johnson's extensive portfolio of healthcare products. Find solutions to meet your medical and wellness needs.